Chief Executive Officer
Robert W. Sims, MBA
Military veteran with 20 years of progressive industry experience involving design, development, and launch of device, diagnostic and therapeutic products across multiple specialties.
Chief Legal Officer
Manya Deehr, JD
25 years of collaborative experience facilitating debt Financing and IPO activity for drug discover, development and commercialization deals in excess of $25B.
Chief Science Officer
Shanta Bantia, PhD
20+ years in R&D, grant procurement, and clinical trial operations; Dr. Bantia has raised an excess of $200M via grants, holds multiple U.S. patents, and has advanced several compounds to market.
Chief Medical Officer
Scott Sweazy, MD
A regarded thought leader with 30+ years of medical practice who has served as a pioneering advisor for first-to-market offerings that enhance patient experiences and improve medical outcomes.